Sana Biotechnology reported financial results and received FDA feedback on its IND filing.
1 report, 1 independent
Updated Aug 12
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Sana Biotechnology reported financial results and received FDA feedback on its IND filing.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- Sana Biotechnology is advancing its IND application with GMP Master Cell Bank development and trials conducted at Uppsala University Hospital.Sub-event
Sana Biotechnology received FDA feedback on its IND filing and presented results at ADA.1 source
Keep exploring
The entities involved
-
Sana Biotechnology
biotechnology company
Nothing else this week.
- FDA
Related events
- Forbes reported on recent drug filings submitted to the FDA and the European Medicines Agency.
- Cloudbreak Pharma Inc. intends to meet with the FDA to review its study findings.
- The FDA is a U.S. government agency, a basic descriptive fact about the regulator.
- Congress and the Senate are considering legislation affecting FDA submissions and drug patent rights.
Coverage
Newest first; wire copies grouped- GlobeNewswireSana Biotechnology Reports Second Quarter 2025 Financial Results and Business Updates Presented positive 6-month clinical results of ongoing type 1 diabetes study showing that hypoimmune-modified pan